Conditional analyses on the T1DGC MHC dataset: Novel associations with type 1 diabetes around HLA-G and confirmation of HLA-B

Genes and Immunity

Volumn 10, Issue 1, 2009, Pages 56-67

  Eike, M C ^a,b   Becker, T ^c,d   Humphreys, K ^d   Olsson, M ^d,e   Lie, B A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF BONN   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; ETHNIC DIFFERENCE; FAMILY STUDY; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DIABETES MELLITUS, TYPE 1; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSATELLITE REPEATS; PHYSICAL CHROMOSOME MAPPING; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 59149093630     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.74     Document Type: Article

References (57)

1. Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J et al Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: A meta-analysis. Tissue Antigens 2007; 70: 110-127.
2. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599-604.
3. Sheehy MJ, Scharf SJ, Rowe JR, Neme de Gimenez MH, Meske LM, Erlich HA et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989; 83 830-835.
4. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-1148.
5. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK et al. Gene map of the extended human MHC. Nat Rev Genet 2004; 5: 889-899.
6. Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE et al. Analysis of SNPs Identifies Major Type 1A Diabetes Locus Telomeric of the MHC. Diabetes 2008; 57: 770-776.
7. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA 2006; 103: 14074-14079.
8. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999; 64: 793-800.
9. Nejentsev S, Gombos Z, Laine AP, Veijola R, Knip M, Simell O et al Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 2000; 49: 2217-2221.
10. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007; 450: 887-892.
11. Zavattari P, Lampis R, Motzo C, Loddo M, Mulargia A, Whalen M et al Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. Hum Mol Genet 2001; 10 881-889.
12. Johansson S, Lie BA, Todd JA, Pociot F, Nerup J, Cambon-Thomsen A et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLADQB1, -DQA1 and -DRB1. Genes Immun 2003; 4: 46-53.
13. Rich SS, Concannon P, Erlich H, Julier C, Morahan G, Nerup J et al The Type 1 Diabetes Genetics Consortium. Ann NY Acad Sci 2006; 1079: 1-8.
14. Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, Hunt S et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005; 76: 634-646.
15. Yunis EJ, Larsen CE, Fernandez-Vina M, Awdeh ZL, Romero T, Hansen JA et al. Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks. Tissue Antigens 2003; 62: 1-20.
16. Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL. Ancestral haplotypes: Conserved population MHC haplotypes. Hum Immunol 1992; 34: 242-252.
17. Alper CA, Awdeh Z, Yunis EJ. Conserved, extended MHC haplotypes. Exp Clin Immunogenet 1992; 9: 58-71.
18. Aly TA, Eller E, Ide A, Gowan K, Babu SR, Erlich HA et al. Multi-SNP analysis of MHC region: Remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 2006; 55: 1265-1269.
19. Blomhoff A, Olsson M, Johansson S, Akselsen HE, Pociot F, Nerup J et al. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes. Genes Immun 2006; 7: 130-140.
20. Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 2003; 12 647-656.
21. Alper CA, Larsen CE, Dubey DP, Awdeh ZL, Fici DA, Yunis EJ. The haplotype structure of the human major histocompatibility complex. Hum Immunol 2006; 67: 73-84.
22. Pruitt KD, Tatusova T, Maglott DR. NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007; 35 (database issue): D61-D65.
23. Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C et al Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005; 76: 349-357.
24. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L et al. Allele-specific targeting of micro-RNAs to HLA-G and risk of asthma. Am J Hum Genet 2007; 81: 829-834.
25. Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C et al. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 2006; 55: 1214-1222.
26. Nejentsev S, Reijonen H, Adojaan B, Kovalchuk L, Sochnevs A, Schwartz EI et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 1997; 46: 1888-1892.
27. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to Type 1 Diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005; 66: 301-313.
28. Bugawan TL, Klitz W, Alejandrino M, Ching J, Panelo A, Solfelix CM et al. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 2002; 59: 452-469.
29. Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A et al Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: Association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls. Hum Immunol 2008; 69: 291-300.
30. de Jersey J, Snelgrove SL, Palmer SE, Teteris SA, Mullbacher A, Miller JF et al. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice. Proc Natl Acad Sci USA 2007; 104: 1295-1300.
31. Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol 1996; 157: 3688-3693.
32. Utsugi T, Yoon JW, Park BJ, Imamura M, Averill N, Kawazu S et al. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo. Diabetes 1996; 45: 1121-1131.
33. Sumida T, Furukawa M, Sakamoto A, Namekawa T, Maeda T, Zijlstra M et al. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol 1994; 6: 1445-1449.
34. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994; 43: 505-509.
35. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA et al. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994; 43: 500-504.
36. Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in sweden. Am J Hum Genet 2006; 79: 614-627.
37. Qu HQ, Marchand L, Szymborski A, Grabs R, Polychronakos C. The association between type 1 diabetes and the ITPR3 gene polymorphism due to linkage disequilibrium with HLA class II. Genes Immun 2008; 9: 264-266.
38. Erlich HA, Rotter JI, Chang JD, Shaw SJ, Raffel LJ, Klitz W et al. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes 1996; 45: 610-614.
39. Cruz TD, Valdes AM, Santiago A, Frazer de Llado T, Raffel LJ, Zeidler A et al. DPB1 alleles are associated with type 1 diabetes susceptibility in multiple ethnic groups. Diabetes 2004; 53: 2158-2163.
40. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000; 49: 121-125.
41. Valdes AM, Noble JA, Genin E, Clerget-Darpoux F, Erlich HA, Thomson G. Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1. Genet Epidemiol 2001; 21: 212-223.
42. Cucca F, Dudbridge F, Loddo M, Mulargia AP, Lampis R, Angius E et al The HLA-DPB1 - associated component of the IDDM1 and its relationship to the major loci HLA-DQB1, -DQA1, and -DRB1. Diabetes 2001; 50: 1200-1205.
43. Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, Miao D et al. HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population. Diabetes 2007; 56: 2405-2409.
44. Lie BA, Akselsen HE, Joner G, Dahl-Jorgensen K, Ronningen KS, Thorsby E et al. HLA associations in insulin-dependent diabetes mellitus: No independent association to particular DP genes. Hum Immunol 1997; 55: 170-175.
45. Johansson S, Lie BA, Pociot F, Nerup J, Cambon-Thomsen A, Kockum I et al. HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. Tissue Antigens 2003; 61: 344-351.
46. Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J et al Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. Immunogenetics 2008; 60: 1-18.
47. Cordell HJ, Barratt BJ, Clayton DG. Case/pseudocontrol analysis in genetic association studies: A unified framework for detection of genotype and haplotype associations, genegene and gene-environment interactions, and parent-of-origin effects. Genet Epidemiol 2004; 26: 167-185.
48. Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004; 27: 21-32.
49. The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-796.
50. O'Connell JR, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266.
51. Undlien DE, Friede T, Rammensee HG, Joner G, Dahl-Jorgensen K, Sovik O et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
52. Wigginton JE, Abecasis GR. PEDSTATS: Descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-3447.
53. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
54. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
55. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-141.
56. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21 263-265.
57. Abecasis GR, Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics 2000; 16: 182-183.